WHO Approves Mpox Diagnostic Test, Hoping to Stop Spread of Virus
- Abbott product is first to receive emergency use listing
- Delays in confirming African mpox cases raise risk of spread
Patients receive injections to treat mpox at the Kavumu hospital in Kabare territory, Democratic Republic of Congo.
Photographer: Arlette Bashizi/BloombergThis article is for subscribers only.
The first diagnostic test for mpox has been approved by the World Health Organization in a bid to expand its availability and stop the spread of lethal outbreaks of the disease in Africa.
Testing for the illness that has already killed 866 people in Africa this year is insufficient and improving surveillance to limit contagion is crucial, the global health agency said.